Tracxn, profile picture
Uploaded byTracxn
PDF, PPTX1,345 views

Tracxn Research — Genomics Landscape, November 2016

The genomics report provides an overview of entrepreneur activity, investment trends, major investors, and exits in the genomics sector. It analyzes over 4,800 companies in sectors like biotech and diagnostics. Key findings include that the number of genomics companies founded and funded rounds have grown year-over-year, with over $18.6 billion invested since 2015. Major investors include ARCH Venture Partners, Illumina, and Sequoia Capital. Recent exits include NantHealth's $765 million IPO and Illumina's acquisition of GenoSpace. The report also analyzes subsectors and provides company profiles.

Embed presentation

Download as PDF, PPTX
1 / 144
2 / 144
3 / 144
4 / 144
5 / 144
6 / 144
7 / 144
8 / 144
9 / 144
10 / 144
11 / 144
12 / 144
13 / 144
14 / 144
15 / 144
16 / 144
17 / 144
18 / 144
19 / 144
20 / 144
21 / 144
22 / 144
23 / 144
24 / 144
25 / 144
26 / 144
27 / 144
28 / 144
29 / 144
30 / 144
31 / 144
32 / 144
33 / 144
34 / 144
35 / 144
36 / 144
37 / 144
38 / 144
39 / 144
40 / 144
41 / 144
42 / 144
43 / 144
44 / 144
45 / 144
46 / 144
47 / 144
48 / 144
49 / 144
50 / 144
51 / 144
52 / 144
53 / 144
54 / 144
55 / 144
56 / 144
57 / 144
58 / 144
59 / 144
60 / 144
61 / 144
62 / 144
63 / 144
64 / 144
65 / 144
66 / 144
67 / 144
68 / 144
69 / 144
70 / 144
71 / 144
72 / 144
73 / 144
74 / 144
75 / 144
76 / 144
77 / 144
78 / 144
79 / 144
80 / 144
81 / 144
82 / 144
83 / 144
84 / 144
85 / 144
86 / 144
87 / 144
88 / 144
89 / 144
90 / 144
91 / 144
92 / 144
93 / 144
94 / 144
95 / 144
96 / 144
97 / 144
98 / 144
99 / 144
100 / 144
101 / 144
102 / 144
103 / 144
104 / 144
105 / 144
106 / 144
107 / 144
108 / 144
109 / 144
110 / 144
111 / 144
112 / 144
113 / 144
114 / 144
115 / 144
116 / 144
117 / 144
118 / 144
119 / 144
120 / 144
121 / 144
122 / 144
123 / 144
124 / 144
125 / 144
126 / 144
127 / 144
128 / 144
129 / 144
130 / 144
131 / 144
132 / 144
133 / 144
134 / 144
135 / 144
136 / 144
137 / 144
138 / 144
139 / 144
140 / 144
141 / 144
142 / 144
143 / 144
144 / 144
Genomics Report – November 2016 Tracxn World’s Largest Startup Research Platform 2
Genomics Report – November 20163 Contents Topic Page No. Scope of Report 04 Entrepreneur Activity 06 Investment Trend 08 Who is Investing 19 Exit Outlook - IPO, Acquisitions 23 Sub Sector Analysis 27 Interesting Companies 46 Company List 54 Team 143
Genomics Report – November 20164 Sector Overview Scope of report The report includes companies which are providing products and services for high-throughput sequencing; developing sequencing technologies; developing tools (or softwares) and providing services for sequencing data analysis; providing diagnostic products and services that use high-throughput sequencing to assess the risk of development of disease in asymptomatic individuals, detect presence of a disease/condition, or to determine best treatment regimens for diagnosed patients. We have excluded clinical laboratories that provides sequencing services for diagnostics without their own proprietary technology. The scope of this report includes equity as well as debt funding received by the companies.
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 5
Genomics Report – November 2016 39 54 64 70 79 49 10 0 18 36 54 72 90 2010 2011 2012 2013 2014 2015 2016 NumberofCompanies 6 YoY – Number of companies founded Foundation Medicine Personalis Guardant Health Human Longevity Inivata iCarbonX Grail Bio Med fusion Fulgent Diagnostics Invitae Color Genomics Arivale Helix ReadCoor
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 7
Genomics Report – November 20168 YoY – Number of Rounds and Total Funding Note: The funding includes debt rounds also. $146M $327M $646M $373M $560M $536M $1.5B $1.6B $1.7B 25 45 53 44 76 76 89 113 91 0 24 48 72 96 120 0 360 720 1080 1440 1800 2008 2009 2010 2011 2012 2013 2014 2015 2016 NumberofRounds FundingAmount(inMillions) Funding Amount Number of Rounds
Genomics Report – November 20169 YoY – Number of Rounds by Stage 7 22 24 23 39 19 25 34 33 46 47 56 12 16 16 17 19 13 0 24 48 72 96 120 2011 2012 2013 2014 2015 2016 NumberofRounds Seed Early Late
Genomics Report – November 201610 YoY – Funding by Stage $6M $16M $17M $24M $35M $17M $171M $255M $193M $875M $603M $1.3B $195M $279M $322M $438M $727M $414M 0 400 800 1200 1600 2000 2011 2012 2013 2014 2015 2016 TotalFundingAmount(inMillions) Seed Early Late
Genomics Report – November 201611 Average Ticket Size – Early Stage $0.9M $0.9M $0.8M $1.3M $1.1M $0.9M $6.7M $5.5M $4.0M $7.8M $13.0M $23.5M $8.4M $8.6M $8.0M $45.7M $17.6M $29.1M 0.0 10.0 20.0 30.0 40.0 50.0 2011 2012 2013 2014 2015 2016 FundingAmount(inMillions) Seed Series A Series B
Genomics Report – November 201612 Top investments in last one year (1/5) Company Funding Amount Round Name Date Investors humanlongevity.com Human Longevity (San Diego, 2013) $220M Series B Apr-2016 GE Ventures, Illumina, Celgene icarbonx.com iCarbonX (Shenzhen, 2015) $155M Series A Apr-2016 Zhongyuan Union Stem Cell Bioengineering, Tencent 23andme.com 23andMe (Mountain View, 2006) $115M Series E Oct-2015 Fidelity Investments, WuXi Healthcare Ventures, Casdin Capital, Illumina, NEA, MPM Capital, GV, Xfund grailbio.com Grail Bio (San Diego, 2016) $100M Series A Jan-2016 Illumina, ARCH Venture Partners, Sutter Hill Ventures, Bezos Expeditions guardanthealth.com Guardant Health (Redwood City, 2012) $100M Series D Jan-2016 Orbimed, Khosla Ventures, Sequoia Capital, Lightspeed Venture Partners, Pejman Mar Ventures, Formation 8, Heritage Group lasergen.com Lasergen (Houston, 2002) $80M PE Mar-2016 Agilent codiakbio.com Codiak BioSciences (Woburn, 2015) $61M Series B Jan-2016 Flagship Ventures, ARCH Venture Partners, Alexandria Real Estate Equities, Fidelity Investments
Genomics Report – November 201613 Top investments in last one year (2/5) Company Funding Amount Round Name Date Investors 10xgenomics.com 10X Genomics (Pleasanton, 2012) $55M Series C Mar-2016 Paladin Capital Group, SoftBank, Fidelity Investments, Foresite Capital, Venrock nanthealth.com NantHealth (Culver City, 2007) $53M Series C Jan-2016 getcolor.com Color Genomics (Burlingame, 2013) $45M Series B Sep-2016 General Catalyst Partners, 8VC, Khosla Ventures, 8VC inivata.com Inivata (Cambridge, 2014) $45M Series A Jan-2016 Imperial Innovations, Cambridge Capital Group, JJDC, Woodford Investment Management sbgenomics.com Seven Bridges Genomics (Cambridge, 2009) $45M Series A Feb-2016 icarbonx.com iCarbonX (Shenzhen, 2015) $45M Series A Jul-2016 China Bridge Capital accuragen.com AccuraGen (Menlo Park, 2013) $40M Series B Jun-2016 Decheng Capital, Temasek, DT Capital Partners, StartX, Nan Fung Group pathway.com Pathway Genomics (San Diego, 2008) $40M Series E Jan-2016 IBM Watson
Genomics Report – November 201614 Top investments in last one year (3/5) Company Funding Amount Round Name Date Investors codiakbio.com Codiak BioSciences (Woburn, 2015) $31M Series A Nov-2015 ARCH Venture Partners, Fidelity Investments, Alexandria Real Estate Equities, Flagship Ventures veritasgenetics.com Veritas Genetics (Danvers, 2014) $30M Series B Oct-2016 Lilly Asia Ventures, Trustbridge Partners, Simcere Pharma fulgentdiagnostics.com Fulgent Diagnostics (Temple City, 2011) $27M Series A May-2016 centrilliontech.com Centrillion Technologies (Palo Alto, 2009) $27M Series C May-2016 syapse.com Syapse (Palo Alto, 2008) $25M Series C Jan-2016 Ascension Ventures, Social Capital, Safeguard Scientifics omicia.com Omicia (Oakland, 2009) $23M Series B Jun-2016 UPMC, Roche, LDV Partners, Ping An Ventures, ARTIS Ventures readcoor.com ReadCoor (Cambridge, 2016) $23M Series A Sep-2016 Decheng Capital, Lilly Asia Ventures, Vivo Capital biodesix.com Biodesix (Broomfield, 2005) $22M Series F Feb-2016
Genomics Report – November 201615 Top investments in last one year (4/5) Company Funding Amount Round Name Date Investors personalgenome.com Personal Genome (Baltimore, 2010) $21M Series A Oct-2015 NEA, Windham Venture Partners cambridge-epigenetix.com Cambridge Epigenetix (Cambridge, 2012) $21M Series B Mar-2016 GV, Sequoia Capital, Syncona Partners, New Science Ventures, University of Cambridge genomind.com Genomind (King Of Prussia, 2009) $21M Series A Jul-2016 Claritas Capital singleragenomics.com Singlera Genomics (La Jolla, 2014) $20M Series A Aug-2016 Lilly Asia Ventures, Green Pine Capital Partners, CDBI Partners purigenbio.com Purigen Biosystems (Pleasanton, 2012) $18M Series A May-2016 5AM Ventures, Roche, StartX pillar-biosciences.com Pillar Biosciences (Natick, 2013) $18M Series A May-2016 enterome.fr Enterome (Paris, 2012) $17M Series C Apr-2016 Seventure Partners, Lundbeckfond Ventures, Nestle Health Science exosomedx.com Exosome Diagnostics (New York City, 2008) $15M Series B Jan-2016
Genomics Report – November 201616 Top investments in last one year (5/5) Company Funding Amount Round Name Date Investors icarbonx.com iCarbonX (Shenzhen, 2015) $15M Series A Jan-2016 Zhongyuan Union Stem Cell Bioengineering assurexhealth.com Assurex Health (Mason, 2006) $15M Series D Dec-2015 Sequoia Capital, Mayo Clinic, Claremont Creek Ventures, Cincinnati Childrens Hospital Medical Center, Cross Creek Advisors clinicalgenomics.com Clinical Genomics (Sydney, 2006) $15M Series A Mar-2016 One Ventures sophiagenetics.com Sophia Genetics (Lausanne, 2011) $15M Series C Dec-2015 caredxinc.com CareDx (Brisbane, 2000) $14M PE Apr-2016 actgenomics.com ACT Genomics (Taipei, 2014) $13M Series B May-2016 Hotung Group, China Development Financial Holding, pidc.com.tw, UMC Capital strataoncology.com Strata Oncology (Ann Arbor, 2015) $12M Series A Jun-2016 Arboretum Ventures, Baird Capital, eLab Ventures bluebee.com Bluebee (Delft, 2011) $11M Series A Mar-2016 Capricorn Venture Partners, Korys, Buysse & Partners
Genomics Report – November 201617 Funnel view of Sector Percent of Previous 67% 58% 45% 88 58 112 249 428 642 0 140 280 420 560 700 M&A & IPO Late Series B Series A Funded Founded Number of Companies
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 18
Genomics Report – November 201619 Most Active Investors in Sector 8 8 8 7 7 6 6 5 5 5 0 2 4 5 7 9 Mohr Davidow Ventures Orbimed Sequoia Capital ARCH Venture Partners Illumina KPCB Sutter Hill Ventures Casdin Capital IndieBio Roche TotalNumberofRounds Pacific Biosciences Guardant Health Guardant Health Illumina Oxford Nanopore Technologies Pacific Biosciences Pacific Biosciences Adaptive Biotechnologies Ranomics Foundation Medicine 23andMe Invitae Natera Grail Bio Adaptive Biotechnologies CareDx Illumina 23andMe Girihlet Stratos Genomics
Genomics Report – November 201620 Where are Top Investors investing
Genomics Report – November 201621 Top Investor by Stage of Entry
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 22
Genomics Report – November 201623 Top IPOs in last three years IPO Date Company Overview Funding Amount Ticker Jun-2016 nanthealth.com NantHealth (Culver City, 2007) Combining medical data and patients' genetic information to find individualized treatment for cancer and other diseases Blackberry, Blackstone, Verizon, Allscripts, Celgene, Kuwait Investment Authority $765M NH Nov-2015 oncovista.com OncoVista (San Antonio, 2004) Develops therapeutics and diagnostics for cancer. Chicago Venture Partners $65M OVIT Jun-2015 natera.com Natera (Redwood City, 2004) Diagnostics company specializing in prenatal and pre-implantation diagnostics. Lightspeed Venture Partners, Sequoia Capital, Orbimed, Founders Fund, Sofinnova Ventures, Harmony Partners, Claremont Creek Ventures, RA Capital Management, Alafi Capital, Jennison Associates, Franklin Templeton, HRC Fertility, Capital Group, Claremont Creek Ventures, HealthCor Partners $152.1M NTRA Feb-2015 invitae.com Invitae (San Francisco, 2012) A genetic information company. Orbimed, Casdin Capital, Thomas, The Broe Group, Decheng Capital, Deerfield, Genesys Capital, Genomic Health, Wellington Management, Rock Springs Capital, Redmile Group, Perceptive Advisors $189.56M NVTA Jul-2014 caredxinc.com CareDx (Brisbane, 2000) Predicting risk of transplant rejection for heart transplant patients. KPCB, Intel Capital, Silicon Valley Bank, Integral Capital Partners, TPG Growth, Duff Ackerman & Goodrich, Burrill and Company, New Leaf Ventures, Sprout Group, TPG, Double Bottom Line Investors, Oxford Finance, Leader Ventures, Bristol-Myers Squibb, gehealthcarefinance.com, DBL Partners $114.82M CDNA Nov-2013 veracyte.com Veracyte (San Francisco, 2008) Genomic solutions for cancer diagnostics KPCB, TPG, Versant Ventures, Domain Associates, GE Ventures $95.65M VCYT
Genomics Report – November 201624 Major Acquisitions in last one year (1/2)
Genomics Report – November 201625 Major Acquisitions in last one year (2/2)
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 26
Genomics Report – November 201627 October 2016Tracxn BlueBox : Biotech 4800+ companies in the sector, 2369 funded in last 5 years, over $18.6B invested since ‘15
Genomics Report – November 201628 October 2016Tracxn BlueBox : Diagnostics (Tech) 1720+ companies in the sector, 810 funded in last 5 years, $4.8B+ invested in 2015/16
Genomics Report – November 201629 Top Business Models by Funding $2.0B $1.8B $1.5B $1.3B $1.0B $0.7B 0.0 0.5 1.0 1.5 2.0 2.5 Clinical Genomics Bioinformatics Sequencing Technology Genetic Testing Liquid Biopsy Research Genomics TotalFundingAmount(inBillions) # Cos. 196 193 31 82 53 87 Avg. Age Jan-09 Apr-09 Apr-07 Jan-09 Jul-09 Nov-06 Adaptive Biotechnologies NantHealth Oxford Nanopore Technologies 23andMe Guardant Health 10X Genomics CareDx Human Longevity Pacific Biosciences Invitae Biodesix RainDance Tech
Genomics Report – November 201630 Clinical Genomics – Business Model Description
Genomics Report – November 201631 Clinical Genomics – Entrepreneur Activity and Investment Trend
Genomics Report – November 201632 Clinical Genomics – Most Funded Companies
Genomics Report – November 201633 Bioinformatics – Business Model Description
Genomics Report – November 201634 Bioinformatics – Entrepreneur Activity and Investment Trend
Genomics Report – November 201635 Bioinformatics – Most Funded Companies
Genomics Report – November 201636 Sequencing Technology – Business Model Description
Genomics Report – November 201637 Sequencing Technology – Entrepreneur Activity and Investment Trend
Genomics Report – November 201638 Sequencing Technology – Most Funded Companies
Genomics Report – November 201639 Genetic Testing – Business Model Description
Genomics Report – November 201640 Genetic Testing – Entrepreneur Activity and Investment Trend
Genomics Report – November 201641 Genetic Testing – Most Funded Companies
Genomics Report – November 201642 Liquid Biopsy – Business Model Description
Genomics Report – November 201643 Liquid Biopsy – Entrepreneur Activity and Investment Trend
Genomics Report – November 201644 Liquid Biopsy – Most Funded Companies
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 45
Genomics Report – November 201646 Interesting Unfunded Companies Company Overview Business Model tempus.com Tempus (2015, Chicago) Oncology platform for sequencing, analytics and informatics Bioinformatics > Clinical Informatics avatardss.com Avatar DSS (2015, Tampa) Precision treatment support for cancer patients Bioinformatics > Clinical Informatics > Pharmacogenomics Vital Genomics (2015, Boca Raton) Provide physicians with pharmacogenomics technology, training, educational support, and patient communications Clinical Genomics > Pharmacogenomics Saga Diagnostics (2016, Lund) Tests for detection and analysis of circulating tumor DNA Liquid Biopsy Lifenome (2015, NYC) Genomics-driven personal wellness Genetic Testing > Nutrigenomics Curated list of companies by the sector analyst are defined as Interesting
Genomics Report – November 201647 Interesting Seed Companies
Genomics Report – November 201648 Interesting Series A Companies
Genomics Report – November 201649 Interesting Series B Companies
Genomics Report – November 201650 Interesting Late Stage Companies
Genomics Report – November 201651 Interesting Late Stage Companies
Genomics Report – November 201652 Top Funded Deadpooled Companies
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 53
Genomics Report – November 201654
Genomics Report – November 201655 Genomics – Company List Clinical Genomics Bioinformatics Sequencing Technology Genetic Testing Liquid Biopsy Research Genomics 428 FUNDED COMPANIES AND 214 UNFUNDED COMPANIES COVERS THE FOLLOWING SECTORS
Genomics Report – November 201656 Clinical Genomics (1/26) Company Overview Business Model Total Funding MDxHealth (2003, Irvine) Epigenetic tests for personalized cancer assessment and treatment. Seventure Partners, Idinvest Partners, IWT, EuroTransBio, IPSA Epigenetics $94.14M Epigenomics (1998, Berlin) Molecular Diagnostics for Cancer Wellcome Trust, 3i Group, MPM Capital, Abingworth, DVCG, BioChain, Creathor Venture, European Commission Epigenetics $52.05M OncoMethylome (2003, Antwerp) Diagnostics for early detection of cancer Epigenetics $16M Nucleix (2008, Rehovot) Develops non-invasive molecular cancer diagnostic tests Orbimed, Aurum Ventures Epigenetics $11.5M Oxford Biodynamics (2007, Oxford) Biomarker discovery based on epigenetics for personalized diagnostics. Epigenetics $11M MetaStat (2007, Montclair) Develops and commercializes diagnostic tests for the prediction of cancer metastasis. H.C. Wainwright Epigenetics $1.5M Oncgnostics (2012, Jena) Develops epigenetic biomarkers diagnostic tests High-Tech Grunderfonds, Bm-t Beteiligungsmanagement Thuringen, Sparkasse Jena Saale Holzland, STIFT Epigenetics Episona (2013, Los Angeles) Test kit using epigenetics to test male infertility. Epigenetics Go to BM List >> Bioinformatics
Genomics Report – November 201657 Clinical Genomics (2/26) Company Overview Business Model Total Funding RiboMed Biotechnologies (1999, Carlsbad) Personalized diagnostics, prognostics and theranostics based on epigenetics. Epigenetics PrognosDx Health (2008, Palo Alto) Epigenetic testing technology to identify cancer Epigenetics Behavioral Diagnostics (2009, Iowa City) Epigenetics based substance use diagnostics National Institutes of Health Epigenetics Adaptive Biotechnologies (2009, Seattle) Engages in immune-based discoveries and diagnostics by combining high-throughput sequencing & bioinformatics to profile immune cell receptors genes. Illumina, Tiger Global Management, Matrix Partners, Casdin Capital, Celgene, Alexandria Real Estate Equities, BD Biosciences, Foresite Capital, Laboratory Corporation of America, Rock Springs Capital, Viking Global Investors, Senator Investment, National Heart Lung and Blood Institute Immunosequencing $404.35M Sequenta (2008, San Francisco) Immunesequencing for blood cancers Index Ventures, Mohr Davidow Ventures, Celgene, Foresite Capital Immunosequencing $43.46M Repertoire (2014, Ibaraki) TCR/BCR repertoire analysis services The University of Tokyo Edge Capital, Beyond Next Ventures Immunosequencing $6.47M MIODx (2014, San Jose) Diagnostics based on genomics and immunesequencing. Immunosequencing $1.5M Go to BM List >> Bioinformatics
Genomics Report – November 201658 Clinical Genomics (3/26) Company Overview Business Model Total Funding ImmunID (2005, Grenoble) Molecular diagnostics using immune profiling Immunosequencing Enterome (2012, Paris) Therapeutic solutions for diseases associated with abnormalities of the gut microbiome (such as Inflammatory Bowel Diseases). Omnes Capital, Seventure Partners, Lundbeckfond Ventures, INRA Transfert, Lundbeckfonden, Nestle Health Science Microbiomics $39.16M uBiome (2012, San Francisco) Citizen science startup to sequence the human microbiome. Andreessen Horowitz, 500 Startups, Kapor Capital, Bansea, Linden Mobile Ventures, Three Bridges Venture Partners, Milliways Ventures, BoxGroup Microbiomics $4.97M GoodGut (2014, Girona) Diagnosis and treatment of digestive diseases based on intestinal microbiota analysis Caixa Capital Risc, BAGi Microbiomics $852.5k IS-Diagnostics (2011, Amsterdam) Provider of technology that enables the diagnosis, ongoing tracking and management of bacterial populations in various habitats. Microbiomics OmniBiome (2012, San Diego) Diagnostics, therapeutics for pregnancy-associated conditions where there is a substantive link with microbiome / microbiota dysbiosis. Microbiomics Quantibio (2014, Beijing) Focuses on the gene mapping of human gut microbiome Globals Tech. Microbiomics Go to BM List >> Bioinformatics
Genomics Report – November 201659 Clinical Genomics (4/26) Go to BM List >> Bioinformatics
Genomics Report – November 201660 Clinical Genomics (5/26) Go to BM List >> Bioinformatics
Genomics Report – November 201661 Clinical Genomics (6/26) Go to BM List >> Bioinformatics
Genomics Report – November 201662 Clinical Genomics (7/26) Go to BM List >> Bioinformatics
Genomics Report – November 201663 Clinical Genomics (8/26) Go to BM List >> Bioinformatics
Genomics Report – November 201664 Clinical Genomics (9/26) Go to BM List >> Bioinformatics
Genomics Report – November 201665 Clinical Genomics (10/26) Go to BM List >> Bioinformatics
Genomics Report – November 201666 Clinical Genomics (11/26) Go to BM List >> Bioinformatics
Genomics Report – November 201667 Clinical Genomics (12/26) Go to BM List >> Bioinformatics
Genomics Report – November 201668 Clinical Genomics (13/26) Go to BM List >> Bioinformatics
Genomics Report – November 201669 Clinical Genomics (14/26) Go to BM List >> Bioinformatics
Genomics Report – November 201670 Clinical Genomics (15/26) Go to BM List >> Bioinformatics
Genomics Report – November 201671 Clinical Genomics (16/26) Go to BM List >> Bioinformatics
Genomics Report – November 201672 Clinical Genomics (17/26) Go to BM List >> Bioinformatics
Genomics Report – November 201673 Clinical Genomics (18/26) Go to BM List >> Bioinformatics
Genomics Report – November 201674 Clinical Genomics (19/26) Go to BM List >> Bioinformatics
Genomics Report – November 201675 Clinical Genomics (20/26) Go to BM List >> Bioinformatics
Genomics Report – November 201676 Clinical Genomics (21/26) Go to BM List >> Bioinformatics
Genomics Report – November 201677 Clinical Genomics (22/26) Go to BM List >> Bioinformatics
Genomics Report – November 201678 Clinical Genomics (23/26) Go to BM List >> Bioinformatics
Genomics Report – November 201679 Clinical Genomics (24/26) Go to BM List >> Bioinformatics
Genomics Report – November 201680 Clinical Genomics (25/26) Go to BM List >> Bioinformatics
Genomics Report – November 201681 Clinical Genomics (26/26) Go to BM List >> Bioinformatics
Genomics Report – November 201682 Bioinformatics (1/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201683 Bioinformatics (2/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201684 Bioinformatics (3/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201685 Bioinformatics (4/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201686 Bioinformatics (5/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201687 Bioinformatics (6/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201688 Bioinformatics (7/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201689 Bioinformatics (8/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201690 Bioinformatics (9/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201691 Bioinformatics (10/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201692 Bioinformatics (11/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201693 Bioinformatics (12/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201694 Bioinformatics (13/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201695 Bioinformatics (14/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201696 Bioinformatics (15/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201697 Bioinformatics (16/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201698 Bioinformatics (17/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 201699 Bioinformatics (18/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016100 Bioinformatics (19/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016101 Bioinformatics (20/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016102 Bioinformatics (21/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016103 Bioinformatics (22/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016104 Bioinformatics (23/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016105 Bioinformatics (24/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016106 Bioinformatics (25/25) Clinical Genomics << Go to BM List >> Sequencing Technology
Genomics Report – November 2016107 Sequencing Technology (1/5) Bioinformatics << Go to BM List >> Genetic Testing
Genomics Report – November 2016108 Sequencing Technology (2/5) Bioinformatics << Go to BM List >> Genetic Testing
Genomics Report – November 2016109 Sequencing Technology (3/5) Bioinformatics << Go to BM List >> Genetic Testing
Genomics Report – November 2016110 Sequencing Technology (4/5) Bioinformatics << Go to BM List >> Genetic Testing
Genomics Report – November 2016111 Sequencing Technology (5/5) Bioinformatics << Go to BM List >> Genetic Testing
Genomics Report – November 2016112 Genetic Testing (1/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016113 Genetic Testing (2/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016114 Genetic Testing (3/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016115 Genetic Testing (4/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016116 Genetic Testing (5/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016117 Genetic Testing (6/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016118 Genetic Testing (7/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016119 Genetic Testing (8/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016120 Genetic Testing (9/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016121 Genetic Testing (10/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016122 Genetic Testing (11/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
Genomics Report – November 2016123 Liquid Biopsy (1/7) Genetic Testing << Go to BM List >> Research Genomics
Genomics Report – November 2016124 Liquid Biopsy (2/7) Genetic Testing << Go to BM List >> Research Genomics
Genomics Report – November 2016125 Liquid Biopsy (3/7) Genetic Testing << Go to BM List >> Research Genomics
Genomics Report – November 2016126 Liquid Biopsy (4/7) Genetic Testing << Go to BM List >> Research Genomics
Genomics Report – November 2016127 Liquid Biopsy (5/7) Genetic Testing << Go to BM List >> Research Genomics
Genomics Report – November 2016128 Liquid Biopsy (6/7) Genetic Testing << Go to BM List >> Research Genomics
Genomics Report – November 2016129 Liquid Biopsy (7/7) Genetic Testing << Go to BM List >> Research Genomics
Genomics Report – November 2016130 Research Genomics (1/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016131 Research Genomics (2/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016132 Research Genomics (3/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016133 Research Genomics (4/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016134 Research Genomics (5/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016135 Research Genomics (6/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016136 Research Genomics (7/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016137 Research Genomics (8/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016138 Research Genomics (9/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016139 Research Genomics (10/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016140 Research Genomics (11/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016141 Research Genomics (12/12) Liquid Biopsy << Go to BM List
Genomics Report – November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 142
Genomics Report – November 2016143 Team 143 Shubham Garg Senior Analyst, Life Sciences Subhabrata Pal Lead Analyst, Life Sciences Vikash Peesapati Lead Analyst, Life Sciences
Genomics Report – November 2016144

More Related Content

PDF
Tracxn Research: Waste & Water Management Landscape, September 2016
byTracxn
 
PDF
Tracxn Research — Enterprise Storage Landscape, November 2016
byTracxn
 
PDF
Tracxn Startup Research — Life Sciences Landscape, October 2016
byTracxn
 
PDF
Tracxn Research — Sales Force Automation Landscape, November 2016
byTracxn
 
PDF
Tracxn Research — Crowdfunding Landscape, November 2016
byTracxn
 
PDF
Tracxn Research — Electric Vehicles Landscape, October 2016
byTracxn
 
PDF
Tracxn Research — Fitness and Wellness Landscape, October 2016
byTracxn
 
PDF
Tracxn Research — Online Photos Landscape, October 2016
byTracxn
 
Tracxn Research: Waste & Water Management Landscape, September 2016
byTracxn
 
Tracxn Research — Enterprise Storage Landscape, November 2016
byTracxn
 
Tracxn Startup Research — Life Sciences Landscape, October 2016
byTracxn
 
Tracxn Research — Sales Force Automation Landscape, November 2016
byTracxn
 
Tracxn Research — Crowdfunding Landscape, November 2016
byTracxn
 
Tracxn Research — Electric Vehicles Landscape, October 2016
byTracxn
 
Tracxn Research — Fitness and Wellness Landscape, October 2016
byTracxn
 
Tracxn Research — Online Photos Landscape, October 2016
byTracxn
 

What's hot

PDF
Tracxn Research — Consumer Robotics Landscape, October 2016
byTracxn
 
PDF
Tracxn Research Energy Efficiency Landscape, November 2016
byTracxn
 
PDF
Tracxn Research — Investment Tech Landscape, October 2016
byTracxn
 
PDF
Tracxn Research — Business Intelligence Landscape, September 2016
byTracxn
 
PDF
Tracxn Research — Immuno-Oncology Landscape, September 2016
byTracxn
 
PDF
Tracxn Research — Business Intelligence Landscape, December 2016
byTracxn
 
PDF
Tracxn Research — Ecommerce Enablers Landscape, November 2016
byTracxn
 
PDF
Tracxn Research — Mobile Dev Tools Landscape, November 2016
byTracxn
 
PDF
Tracxn SCM Software Startup Landscape, July 2016
byTracxn
 
PDF
Tracxn Startup Research — Smart Homes Landscape, September 2016
byTracxn
 
PDF
Tracxn Startup Research — Mom and Baby Care Landscape, August 2016
byTracxn
 
PDF
Tracxn Research Ad Tech Landscape, October 2016
byTracxn
 
PDF
Tracxn Remittance Startup Landscape Report, July 2016
byTracxn
 
PDF
Tracxn Research - Logistics Tech Landscape, October 2016
byTracxn
 
PDF
Tracxn Report: Subscription Commerce Startup Landscape, July 2016
byTracxn
 
PPTX
Home Improvement India Report April 2016
byTracxn
 
PDF
Tracxn Food Tech Startup Landscape, July 2016
byTracxn
 
PDF
Tracxn Research — Self Learning Landscape, November 2016
byTracxn
 
PDF
Tracxn Research — Banking Tech Landscape, November 2016
byTracxn
 
PDF
Tracxn Research — Insurance Tech Landscape, October 2016
byTracxn
 
Tracxn Research — Consumer Robotics Landscape, October 2016
byTracxn
 
Tracxn Research Energy Efficiency Landscape, November 2016
byTracxn
 
Tracxn Research — Investment Tech Landscape, October 2016
byTracxn
 
Tracxn Research — Business Intelligence Landscape, September 2016
byTracxn
 
Tracxn Research — Immuno-Oncology Landscape, September 2016
byTracxn
 
Tracxn Research — Business Intelligence Landscape, December 2016
byTracxn
 
Tracxn Research — Ecommerce Enablers Landscape, November 2016
byTracxn
 
Tracxn Research — Mobile Dev Tools Landscape, November 2016
byTracxn
 
Tracxn SCM Software Startup Landscape, July 2016
byTracxn
 
Tracxn Startup Research — Smart Homes Landscape, September 2016
byTracxn
 
Tracxn Startup Research — Mom and Baby Care Landscape, August 2016
byTracxn
 
Tracxn Research Ad Tech Landscape, October 2016
byTracxn
 
Tracxn Remittance Startup Landscape Report, July 2016
byTracxn
 
Tracxn Research - Logistics Tech Landscape, October 2016
byTracxn
 
Tracxn Report: Subscription Commerce Startup Landscape, July 2016
byTracxn
 
Home Improvement India Report April 2016
byTracxn
 
Tracxn Food Tech Startup Landscape, July 2016
byTracxn
 
Tracxn Research — Self Learning Landscape, November 2016
byTracxn
 
Tracxn Research — Banking Tech Landscape, November 2016
byTracxn
 
Tracxn Research — Insurance Tech Landscape, October 2016
byTracxn
 

Viewers also liked

PDF
Tracxn research - PaaS Landscape, December 2016
byTracxn
 
PDF
Tracxn Research - ERP Landscape, February 2017
byTracxn
 
PDF
Tracxn Research - Solar Energy Landscape, February 2017
byTracxn
 
PDF
Tracxn Research — Legal Tech Landscape, December 2016
byTracxn
 
PDF
Tracxn Research — IoT Infrastructure Landscape, December 2016
byTracxn
 
PDF
Tracxn Research — Fintech India Landscape, October 2016
byTracxn
 
PDF
Tracxn Research - Smart Grid Landscape, January 2017
byTracxn
 
PDF
Tracxn Research — Industrial IoT Landscape, October 2016
byTracxn
 
PDF
Tracxn Research - Industrial Robotics Landscape, February 2017
byTracxn
 
PDF
Tracxn Research - Healthcare Analytics Landscape, February 2017
byTracxn
 
PDF
Tracxn Research - Mobile Advertising Landscape, February 2017
byTracxn
 
PDF
Tracxn Research - Construction Tech Landscape, February 2017
byTracxn
 
PPT
Genomics
byPubudu Gokarella
 
PPTX
Tekla Global BIM Awards 2012
byTrimble / Structures Division
 
PDF
Tracxn Research — Energy Storage Landscape, November 2016
byTracxn
 
PDF
Tracxn Research: Precision Agriculture Landscape, August 2016
byTracxn
 
PDF
Case Study of BIM, Detailing and Modelling
byBDS VirCon
 
PDF
Tracxn Research — Home Improvements Landscape, December 2016
byTracxn
 
PDF
Tracxn Research — New Space Landscape, December 2016
byTracxn
 
PDF
Europe health tech report 2016
byOmar Mohout
 
Tracxn research - PaaS Landscape, December 2016
byTracxn
 
Tracxn Research - ERP Landscape, February 2017
byTracxn
 
Tracxn Research - Solar Energy Landscape, February 2017
byTracxn
 
Tracxn Research — Legal Tech Landscape, December 2016
byTracxn
 
Tracxn Research — IoT Infrastructure Landscape, December 2016
byTracxn
 
Tracxn Research — Fintech India Landscape, October 2016
byTracxn
 
Tracxn Research - Smart Grid Landscape, January 2017
byTracxn
 
Tracxn Research — Industrial IoT Landscape, October 2016
byTracxn
 
Tracxn Research - Industrial Robotics Landscape, February 2017
byTracxn
 
Tracxn Research - Healthcare Analytics Landscape, February 2017
byTracxn
 
Tracxn Research - Mobile Advertising Landscape, February 2017
byTracxn
 
Tracxn Research - Construction Tech Landscape, February 2017
byTracxn
 
Genomics
byPubudu Gokarella
 
Tekla Global BIM Awards 2012
byTrimble / Structures Division
 
Tracxn Research — Energy Storage Landscape, November 2016
byTracxn
 
Tracxn Research: Precision Agriculture Landscape, August 2016
byTracxn
 
Case Study of BIM, Detailing and Modelling
byBDS VirCon
 
Tracxn Research — Home Improvements Landscape, December 2016
byTracxn
 
Tracxn Research — New Space Landscape, December 2016
byTracxn
 
Europe health tech report 2016
byOmar Mohout
 

Similar to Tracxn Research — Genomics Landscape, November 2016

PDF
Tracxn - Life Sciences - Top Business Models - Feb 2022
byTracxn
 
PPTX
Tracxn - Top Business Models - Life Sciences - Apr 2022
byTracxn
 
PPTX
Tracxn - Top Business Models - Life sciences Tech - Mar 2022
byTracxn
 
PPTX
Tracxn - Life Sciences - Top Business Models - Feb 2021
byTracxn
 
PPTX
Tracxn-Life sciences - 17 Aug 2021
byTracxn
 
PPTX
Tracxn - Top Business Models - Life Science - Nov 2021
byTracxn
 
PPTX
Tracxn - Life Sciences - Top Business Models - May 2021
byTracxn
 
PDF
Jonathan Norris
byHealthegy
 
PDF
04 Exec Summ_Shivom
byOscar Chan
 
PDF
Genomic stocks
byKhushboo Dange
 
PDF
Visiongain publishes report: The global genomics market report 2018-2028
byVisiongain
 
PPTX
Top 10 Biotech Startups for Beginners.pptx
byalexbagheriam
 
PDF
Trends in Healthcare Investments and Exits 2016
bySilicon Valley Bank
 
PDF
BioEntrepreneurship: The Business of Biotech
byMaRS Discovery District
 
PDF
The State of Emerging Biotech Companies Investment Deal and Pipeline Trends.pdf
byBioPharma Strategy Advisors
 
PDF
Life Sciences Industry Report 2017 by Xeraya Capital (Hi-Res)
byKumaraguru Veerasamy
 
PDF
Arm q12015 data_report_web_version
byJohn Redaelli
 
PDF
The Current Climate for Medical Technology Investing
byInflection Point Executive Coaching & Consulting for Med/Tech, BioPharma and Healthcare Services
 
PDF
Medical Technology Investing...the current climate
byInflection Point Executive Coaching & Consulting for Med/Tech, BioPharma and Healthcare Services
 
PDF
Status Quo of Genomics Industry
byYasin Memari
 
Tracxn - Life Sciences - Top Business Models - Feb 2022
byTracxn
 
Tracxn - Top Business Models - Life Sciences - Apr 2022
byTracxn
 
Tracxn - Top Business Models - Life sciences Tech - Mar 2022
byTracxn
 
Tracxn - Life Sciences - Top Business Models - Feb 2021
byTracxn
 
Tracxn-Life sciences - 17 Aug 2021
byTracxn
 
Tracxn - Top Business Models - Life Science - Nov 2021
byTracxn
 
Tracxn - Life Sciences - Top Business Models - May 2021
byTracxn
 
Jonathan Norris
byHealthegy
 
04 Exec Summ_Shivom
byOscar Chan
 
Genomic stocks
byKhushboo Dange
 
Visiongain publishes report: The global genomics market report 2018-2028
byVisiongain
 
Top 10 Biotech Startups for Beginners.pptx
byalexbagheriam
 
Trends in Healthcare Investments and Exits 2016
bySilicon Valley Bank
 
BioEntrepreneurship: The Business of Biotech
byMaRS Discovery District
 
The State of Emerging Biotech Companies Investment Deal and Pipeline Trends.pdf
byBioPharma Strategy Advisors
 
Life Sciences Industry Report 2017 by Xeraya Capital (Hi-Res)
byKumaraguru Veerasamy
 
Arm q12015 data_report_web_version
byJohn Redaelli
 
The Current Climate for Medical Technology Investing
byInflection Point Executive Coaching & Consulting for Med/Tech, BioPharma and Healthcare Services
 
Medical Technology Investing...the current climate
byInflection Point Executive Coaching & Consulting for Med/Tech, BioPharma and Healthcare Services
 
Status Quo of Genomics Industry
byYasin Memari
 

More from Tracxn

PPTX
Fintech - India Annual Funding Report - 2024.pptx
byTracxn
 
PPTX
India Tech Annual Funding Report - 2024.pptx
byTracxn
 
PPTX
Canada Tech Annual Funding Report - 2024.pptx
byTracxn
 
PPTX
Environment Tech - SEA Annual Funding Report - 2024 (Old).pptx
byTracxn
 
PPTX
FinTech - SEA Annual Funding Report - 2024 (New).pptx
byTracxn
 
PPTX
FinTech - US Annual Funding Report - 2024.pptx
byTracxn
 
PPTX
Blockchain Technology - SEA Annual Funding Report - 2024.pptx
byTracxn
 
PPTX
FinTech - UK Annual Funding Report - 2024.pptx
byTracxn
 
PPTX
Tracxn - FinTech_-_India_Monthly_Funding_Report
byTracxn
 
PPTX
FinTech_-_India_Monthly_Funding_Report.pptx
byTracxn
 
PPTX
India_Tech_Monthly_Funding_Report.pptx
byTracxn
 
PPTX
India_Tech_Monthly_Funding_Report.pptx
byTracxn
 
PPTX
Tracxn - Top_Business_Models_in_Sustainability_Tech_-_26_Oct_2023
byTracxn
 
PPTX
Tracxn - Southeast Asia Tech Monthly Funding Report
byTracxn
 
PPTX
Tracxn - Top Business Models in Sustainability Tech - 26 Oct 2023
byTracxn
 
PPTX
Tracxn - United States Tech Monthly Funding Report
byTracxn
 
PPTX
Tracxn - Top Business Models in High Tech - 27 Oct 2023
byTracxn
 
PPTX
Tracxn - India Tech Monthly Funding Report
byTracxn
 
PPTX
Tracxn - Top Business Models in Vietnam Tech - 20 Oct 2023
byTracxn
 
PPTX
Tracxn - Top Business Models in Singapore Tech - 19 Oct 2023
byTracxn
 
Fintech - India Annual Funding Report - 2024.pptx
byTracxn
 
India Tech Annual Funding Report - 2024.pptx
byTracxn
 
Canada Tech Annual Funding Report - 2024.pptx
byTracxn
 
Environment Tech - SEA Annual Funding Report - 2024 (Old).pptx
byTracxn
 
FinTech - SEA Annual Funding Report - 2024 (New).pptx
byTracxn
 
FinTech - US Annual Funding Report - 2024.pptx
byTracxn
 
Blockchain Technology - SEA Annual Funding Report - 2024.pptx
byTracxn
 
FinTech - UK Annual Funding Report - 2024.pptx
byTracxn
 
Tracxn - FinTech_-_India_Monthly_Funding_Report
byTracxn
 
FinTech_-_India_Monthly_Funding_Report.pptx
byTracxn
 
India_Tech_Monthly_Funding_Report.pptx
byTracxn
 
India_Tech_Monthly_Funding_Report.pptx
byTracxn
 
Tracxn - Top_Business_Models_in_Sustainability_Tech_-_26_Oct_2023
byTracxn
 
Tracxn - Southeast Asia Tech Monthly Funding Report
byTracxn
 
Tracxn - Top Business Models in Sustainability Tech - 26 Oct 2023
byTracxn
 
Tracxn - United States Tech Monthly Funding Report
byTracxn
 
Tracxn - Top Business Models in High Tech - 27 Oct 2023
byTracxn
 
Tracxn - India Tech Monthly Funding Report
byTracxn
 
Tracxn - Top Business Models in Vietnam Tech - 20 Oct 2023
byTracxn
 
Tracxn - Top Business Models in Singapore Tech - 19 Oct 2023
byTracxn
 

Recently uploaded

PPTX
Geographical Information System Also Known As GIS
bynionyeet
 
PDF
Azure Data Factory Overview for SSIS Developers.pdf
bySrinivas V
 
PPTX
SlideEgg_66421-Data Lifecycle Management-4-3.pptx
byakashsarkar0424
 
PPT
unit-3 Introduction to drawing and instruments part-2.ppt
byalemayehuc1
 
PPTX
Testing-Results-and-Outcomes (1).pptx dfw
bySrini Vasan
 
PPTX
Ch6 Automata & Complexity Theory 2016.pptx
bytechnologyn387
 
PPTX
How to Increase Govt. Local Body Revenue
byNavpal Singh
 
PPTX
2ai_mockinterview.pptx hjijjjjjjjjjnhhbh
bypankajponia112
 
PPTX
NLP Generative artificial intelligence trends
byBasantAgarwal17
 
PPTX
Geographical Information System Also Known As GIS
bynionyeet
 
PPTX
Ollama_RAG_retrivewantedvaluesusingModels.pptx
byanjaneyav00
 
PPT
dnkfgkjcjgkdkfjjyrdoejmmb,ktoyiu0ilfseikk
byGhulamRasool214870
 
PPTX
Pakistan Tableau User Group Event: A guide to Salesforce Certified Data Analyst
byWaqarAhmedShaikh8
 
PDF
NY26_Gov.uk_List__Final__18_12_25.pdf New Years Honours 2026
byHenry Tapper
 
PPTX
Statistical Analysis for Researchers - Presentation - Lecture Two.pptx
byAmgad Fahmy
 
PDF
AI 21.pdf Learn How AI Tools Optimize Decision Making, Marketing, HR, and More
byCA Suvidha Chaplot
 
PPTX
Sales_Analysis_Presentation.pptx dashboard
bydheerendras984
 
PDF
7th International Conference on Artificial Intelligence and Big Data (AIBD 2026)
bymlaij
 
PPTX
RAG_classnoteswith having various ways of publishing the model.pptx
byanjaneyav00
 
PPTX
Big Data Analytics Introduction & Applications.pptx
byprabha345213
 
Geographical Information System Also Known As GIS
bynionyeet
 
Azure Data Factory Overview for SSIS Developers.pdf
bySrinivas V
 
SlideEgg_66421-Data Lifecycle Management-4-3.pptx
byakashsarkar0424
 
unit-3 Introduction to drawing and instruments part-2.ppt
byalemayehuc1
 
Testing-Results-and-Outcomes (1).pptx dfw
bySrini Vasan
 
Ch6 Automata & Complexity Theory 2016.pptx
bytechnologyn387
 
How to Increase Govt. Local Body Revenue
byNavpal Singh
 
2ai_mockinterview.pptx hjijjjjjjjjjnhhbh
bypankajponia112
 
NLP Generative artificial intelligence trends
byBasantAgarwal17
 
Geographical Information System Also Known As GIS
bynionyeet
 
Ollama_RAG_retrivewantedvaluesusingModels.pptx
byanjaneyav00
 
dnkfgkjcjgkdkfjjyrdoejmmb,ktoyiu0ilfseikk
byGhulamRasool214870
 
Pakistan Tableau User Group Event: A guide to Salesforce Certified Data Analyst
byWaqarAhmedShaikh8
 
NY26_Gov.uk_List__Final__18_12_25.pdf New Years Honours 2026
byHenry Tapper
 
Statistical Analysis for Researchers - Presentation - Lecture Two.pptx
byAmgad Fahmy
 
AI 21.pdf Learn How AI Tools Optimize Decision Making, Marketing, HR, and More
byCA Suvidha Chaplot
 
Sales_Analysis_Presentation.pptx dashboard
bydheerendras984
 
7th International Conference on Artificial Intelligence and Big Data (AIBD 2026)
bymlaij
 
RAG_classnoteswith having various ways of publishing the model.pptx
byanjaneyav00
 
Big Data Analytics Introduction & Applications.pptx
byprabha345213
 

Tracxn Research — Genomics Landscape, November 2016

  • 2.
    Genomics Report –November 2016 Tracxn World’s Largest Startup Research Platform 2
  • 3.
    Genomics Report –November 20163 Contents Topic Page No. Scope of Report 04 Entrepreneur Activity 06 Investment Trend 08 Who is Investing 19 Exit Outlook - IPO, Acquisitions 23 Sub Sector Analysis 27 Interesting Companies 46 Company List 54 Team 143
  • 4.
    Genomics Report –November 20164 Sector Overview Scope of report The report includes companies which are providing products and services for high-throughput sequencing; developing sequencing technologies; developing tools (or softwares) and providing services for sequencing data analysis; providing diagnostic products and services that use high-throughput sequencing to assess the risk of development of disease in asymptomatic individuals, detect presence of a disease/condition, or to determine best treatment regimens for diagnosed patients. We have excluded clinical laboratories that provides sequencing services for diagnostics without their own proprietary technology. The scope of this report includes equity as well as debt funding received by the companies.
  • 5.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 5
  • 6.
    Genomics Report –November 2016 39 54 64 70 79 49 10 0 18 36 54 72 90 2010 2011 2012 2013 2014 2015 2016 NumberofCompanies 6 YoY – Number of companies founded Foundation Medicine Personalis Guardant Health Human Longevity Inivata iCarbonX Grail Bio Med fusion Fulgent Diagnostics Invitae Color Genomics Arivale Helix ReadCoor
  • 7.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 7
  • 8.
    Genomics Report –November 20168 YoY – Number of Rounds and Total Funding Note: The funding includes debt rounds also. $146M $327M $646M $373M $560M $536M $1.5B $1.6B $1.7B 25 45 53 44 76 76 89 113 91 0 24 48 72 96 120 0 360 720 1080 1440 1800 2008 2009 2010 2011 2012 2013 2014 2015 2016 NumberofRounds FundingAmount(inMillions) Funding Amount Number of Rounds
  • 9.
    Genomics Report –November 20169 YoY – Number of Rounds by Stage 7 22 24 23 39 19 25 34 33 46 47 56 12 16 16 17 19 13 0 24 48 72 96 120 2011 2012 2013 2014 2015 2016 NumberofRounds Seed Early Late
  • 10.
    Genomics Report –November 201610 YoY – Funding by Stage $6M $16M $17M $24M $35M $17M $171M $255M $193M $875M $603M $1.3B $195M $279M $322M $438M $727M $414M 0 400 800 1200 1600 2000 2011 2012 2013 2014 2015 2016 TotalFundingAmount(inMillions) Seed Early Late
  • 11.
    Genomics Report –November 201611 Average Ticket Size – Early Stage $0.9M $0.9M $0.8M $1.3M $1.1M $0.9M $6.7M $5.5M $4.0M $7.8M $13.0M $23.5M $8.4M $8.6M $8.0M $45.7M $17.6M $29.1M 0.0 10.0 20.0 30.0 40.0 50.0 2011 2012 2013 2014 2015 2016 FundingAmount(inMillions) Seed Series A Series B
  • 12.
    Genomics Report –November 201612 Top investments in last one year (1/5) Company Funding Amount Round Name Date Investors humanlongevity.com Human Longevity (San Diego, 2013) $220M Series B Apr-2016 GE Ventures, Illumina, Celgene icarbonx.com iCarbonX (Shenzhen, 2015) $155M Series A Apr-2016 Zhongyuan Union Stem Cell Bioengineering, Tencent 23andme.com 23andMe (Mountain View, 2006) $115M Series E Oct-2015 Fidelity Investments, WuXi Healthcare Ventures, Casdin Capital, Illumina, NEA, MPM Capital, GV, Xfund grailbio.com Grail Bio (San Diego, 2016) $100M Series A Jan-2016 Illumina, ARCH Venture Partners, Sutter Hill Ventures, Bezos Expeditions guardanthealth.com Guardant Health (Redwood City, 2012) $100M Series D Jan-2016 Orbimed, Khosla Ventures, Sequoia Capital, Lightspeed Venture Partners, Pejman Mar Ventures, Formation 8, Heritage Group lasergen.com Lasergen (Houston, 2002) $80M PE Mar-2016 Agilent codiakbio.com Codiak BioSciences (Woburn, 2015) $61M Series B Jan-2016 Flagship Ventures, ARCH Venture Partners, Alexandria Real Estate Equities, Fidelity Investments
  • 13.
    Genomics Report –November 201613 Top investments in last one year (2/5) Company Funding Amount Round Name Date Investors 10xgenomics.com 10X Genomics (Pleasanton, 2012) $55M Series C Mar-2016 Paladin Capital Group, SoftBank, Fidelity Investments, Foresite Capital, Venrock nanthealth.com NantHealth (Culver City, 2007) $53M Series C Jan-2016 getcolor.com Color Genomics (Burlingame, 2013) $45M Series B Sep-2016 General Catalyst Partners, 8VC, Khosla Ventures, 8VC inivata.com Inivata (Cambridge, 2014) $45M Series A Jan-2016 Imperial Innovations, Cambridge Capital Group, JJDC, Woodford Investment Management sbgenomics.com Seven Bridges Genomics (Cambridge, 2009) $45M Series A Feb-2016 icarbonx.com iCarbonX (Shenzhen, 2015) $45M Series A Jul-2016 China Bridge Capital accuragen.com AccuraGen (Menlo Park, 2013) $40M Series B Jun-2016 Decheng Capital, Temasek, DT Capital Partners, StartX, Nan Fung Group pathway.com Pathway Genomics (San Diego, 2008) $40M Series E Jan-2016 IBM Watson
  • 14.
    Genomics Report –November 201614 Top investments in last one year (3/5) Company Funding Amount Round Name Date Investors codiakbio.com Codiak BioSciences (Woburn, 2015) $31M Series A Nov-2015 ARCH Venture Partners, Fidelity Investments, Alexandria Real Estate Equities, Flagship Ventures veritasgenetics.com Veritas Genetics (Danvers, 2014) $30M Series B Oct-2016 Lilly Asia Ventures, Trustbridge Partners, Simcere Pharma fulgentdiagnostics.com Fulgent Diagnostics (Temple City, 2011) $27M Series A May-2016 centrilliontech.com Centrillion Technologies (Palo Alto, 2009) $27M Series C May-2016 syapse.com Syapse (Palo Alto, 2008) $25M Series C Jan-2016 Ascension Ventures, Social Capital, Safeguard Scientifics omicia.com Omicia (Oakland, 2009) $23M Series B Jun-2016 UPMC, Roche, LDV Partners, Ping An Ventures, ARTIS Ventures readcoor.com ReadCoor (Cambridge, 2016) $23M Series A Sep-2016 Decheng Capital, Lilly Asia Ventures, Vivo Capital biodesix.com Biodesix (Broomfield, 2005) $22M Series F Feb-2016
  • 15.
    Genomics Report –November 201615 Top investments in last one year (4/5) Company Funding Amount Round Name Date Investors personalgenome.com Personal Genome (Baltimore, 2010) $21M Series A Oct-2015 NEA, Windham Venture Partners cambridge-epigenetix.com Cambridge Epigenetix (Cambridge, 2012) $21M Series B Mar-2016 GV, Sequoia Capital, Syncona Partners, New Science Ventures, University of Cambridge genomind.com Genomind (King Of Prussia, 2009) $21M Series A Jul-2016 Claritas Capital singleragenomics.com Singlera Genomics (La Jolla, 2014) $20M Series A Aug-2016 Lilly Asia Ventures, Green Pine Capital Partners, CDBI Partners purigenbio.com Purigen Biosystems (Pleasanton, 2012) $18M Series A May-2016 5AM Ventures, Roche, StartX pillar-biosciences.com Pillar Biosciences (Natick, 2013) $18M Series A May-2016 enterome.fr Enterome (Paris, 2012) $17M Series C Apr-2016 Seventure Partners, Lundbeckfond Ventures, Nestle Health Science exosomedx.com Exosome Diagnostics (New York City, 2008) $15M Series B Jan-2016
  • 16.
    Genomics Report –November 201616 Top investments in last one year (5/5) Company Funding Amount Round Name Date Investors icarbonx.com iCarbonX (Shenzhen, 2015) $15M Series A Jan-2016 Zhongyuan Union Stem Cell Bioengineering assurexhealth.com Assurex Health (Mason, 2006) $15M Series D Dec-2015 Sequoia Capital, Mayo Clinic, Claremont Creek Ventures, Cincinnati Childrens Hospital Medical Center, Cross Creek Advisors clinicalgenomics.com Clinical Genomics (Sydney, 2006) $15M Series A Mar-2016 One Ventures sophiagenetics.com Sophia Genetics (Lausanne, 2011) $15M Series C Dec-2015 caredxinc.com CareDx (Brisbane, 2000) $14M PE Apr-2016 actgenomics.com ACT Genomics (Taipei, 2014) $13M Series B May-2016 Hotung Group, China Development Financial Holding, pidc.com.tw, UMC Capital strataoncology.com Strata Oncology (Ann Arbor, 2015) $12M Series A Jun-2016 Arboretum Ventures, Baird Capital, eLab Ventures bluebee.com Bluebee (Delft, 2011) $11M Series A Mar-2016 Capricorn Venture Partners, Korys, Buysse & Partners
  • 17.
    Genomics Report –November 201617 Funnel view of Sector Percent of Previous 67% 58% 45% 88 58 112 249 428 642 0 140 280 420 560 700 M&A & IPO Late Series B Series A Funded Founded Number of Companies
  • 18.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 18
  • 19.
    Genomics Report –November 201619 Most Active Investors in Sector 8 8 8 7 7 6 6 5 5 5 0 2 4 5 7 9 Mohr Davidow Ventures Orbimed Sequoia Capital ARCH Venture Partners Illumina KPCB Sutter Hill Ventures Casdin Capital IndieBio Roche TotalNumberofRounds Pacific Biosciences Guardant Health Guardant Health Illumina Oxford Nanopore Technologies Pacific Biosciences Pacific Biosciences Adaptive Biotechnologies Ranomics Foundation Medicine 23andMe Invitae Natera Grail Bio Adaptive Biotechnologies CareDx Illumina 23andMe Girihlet Stratos Genomics
  • 20.
    Genomics Report –November 201620 Where are Top Investors investing
  • 21.
    Genomics Report –November 201621 Top Investor by Stage of Entry
  • 22.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 22
  • 23.
    Genomics Report –November 201623 Top IPOs in last three years IPO Date Company Overview Funding Amount Ticker Jun-2016 nanthealth.com NantHealth (Culver City, 2007) Combining medical data and patients' genetic information to find individualized treatment for cancer and other diseases Blackberry, Blackstone, Verizon, Allscripts, Celgene, Kuwait Investment Authority $765M NH Nov-2015 oncovista.com OncoVista (San Antonio, 2004) Develops therapeutics and diagnostics for cancer. Chicago Venture Partners $65M OVIT Jun-2015 natera.com Natera (Redwood City, 2004) Diagnostics company specializing in prenatal and pre-implantation diagnostics. Lightspeed Venture Partners, Sequoia Capital, Orbimed, Founders Fund, Sofinnova Ventures, Harmony Partners, Claremont Creek Ventures, RA Capital Management, Alafi Capital, Jennison Associates, Franklin Templeton, HRC Fertility, Capital Group, Claremont Creek Ventures, HealthCor Partners $152.1M NTRA Feb-2015 invitae.com Invitae (San Francisco, 2012) A genetic information company. Orbimed, Casdin Capital, Thomas, The Broe Group, Decheng Capital, Deerfield, Genesys Capital, Genomic Health, Wellington Management, Rock Springs Capital, Redmile Group, Perceptive Advisors $189.56M NVTA Jul-2014 caredxinc.com CareDx (Brisbane, 2000) Predicting risk of transplant rejection for heart transplant patients. KPCB, Intel Capital, Silicon Valley Bank, Integral Capital Partners, TPG Growth, Duff Ackerman & Goodrich, Burrill and Company, New Leaf Ventures, Sprout Group, TPG, Double Bottom Line Investors, Oxford Finance, Leader Ventures, Bristol-Myers Squibb, gehealthcarefinance.com, DBL Partners $114.82M CDNA Nov-2013 veracyte.com Veracyte (San Francisco, 2008) Genomic solutions for cancer diagnostics KPCB, TPG, Versant Ventures, Domain Associates, GE Ventures $95.65M VCYT
  • 24.
    Genomics Report –November 201624 Major Acquisitions in last one year (1/2)
  • 25.
    Genomics Report –November 201625 Major Acquisitions in last one year (2/2)
  • 26.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 26
  • 27.
    Genomics Report –November 201627 October 2016Tracxn BlueBox : Biotech 4800+ companies in the sector, 2369 funded in last 5 years, over $18.6B invested since ‘15
  • 28.
    Genomics Report –November 201628 October 2016Tracxn BlueBox : Diagnostics (Tech) 1720+ companies in the sector, 810 funded in last 5 years, $4.8B+ invested in 2015/16
  • 29.
    Genomics Report –November 201629 Top Business Models by Funding $2.0B $1.8B $1.5B $1.3B $1.0B $0.7B 0.0 0.5 1.0 1.5 2.0 2.5 Clinical Genomics Bioinformatics Sequencing Technology Genetic Testing Liquid Biopsy Research Genomics TotalFundingAmount(inBillions) # Cos. 196 193 31 82 53 87 Avg. Age Jan-09 Apr-09 Apr-07 Jan-09 Jul-09 Nov-06 Adaptive Biotechnologies NantHealth Oxford Nanopore Technologies 23andMe Guardant Health 10X Genomics CareDx Human Longevity Pacific Biosciences Invitae Biodesix RainDance Tech
  • 30.
    Genomics Report –November 201630 Clinical Genomics – Business Model Description
  • 31.
    Genomics Report –November 201631 Clinical Genomics – Entrepreneur Activity and Investment Trend
  • 32.
    Genomics Report –November 201632 Clinical Genomics – Most Funded Companies
  • 33.
    Genomics Report –November 201633 Bioinformatics – Business Model Description
  • 34.
    Genomics Report –November 201634 Bioinformatics – Entrepreneur Activity and Investment Trend
  • 35.
    Genomics Report –November 201635 Bioinformatics – Most Funded Companies
  • 36.
    Genomics Report –November 201636 Sequencing Technology – Business Model Description
  • 37.
    Genomics Report –November 201637 Sequencing Technology – Entrepreneur Activity and Investment Trend
  • 38.
    Genomics Report –November 201638 Sequencing Technology – Most Funded Companies
  • 39.
    Genomics Report –November 201639 Genetic Testing – Business Model Description
  • 40.
    Genomics Report –November 201640 Genetic Testing – Entrepreneur Activity and Investment Trend
  • 41.
    Genomics Report –November 201641 Genetic Testing – Most Funded Companies
  • 42.
    Genomics Report –November 201642 Liquid Biopsy – Business Model Description
  • 43.
    Genomics Report –November 201643 Liquid Biopsy – Entrepreneur Activity and Investment Trend
  • 44.
    Genomics Report –November 201644 Liquid Biopsy – Most Funded Companies
  • 45.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 45
  • 46.
    Genomics Report –November 201646 Interesting Unfunded Companies Company Overview Business Model tempus.com Tempus (2015, Chicago) Oncology platform for sequencing, analytics and informatics Bioinformatics > Clinical Informatics avatardss.com Avatar DSS (2015, Tampa) Precision treatment support for cancer patients Bioinformatics > Clinical Informatics > Pharmacogenomics Vital Genomics (2015, Boca Raton) Provide physicians with pharmacogenomics technology, training, educational support, and patient communications Clinical Genomics > Pharmacogenomics Saga Diagnostics (2016, Lund) Tests for detection and analysis of circulating tumor DNA Liquid Biopsy Lifenome (2015, NYC) Genomics-driven personal wellness Genetic Testing > Nutrigenomics Curated list of companies by the sector analyst are defined as Interesting
  • 47.
    Genomics Report –November 201647 Interesting Seed Companies
  • 48.
    Genomics Report –November 201648 Interesting Series A Companies
  • 49.
    Genomics Report –November 201649 Interesting Series B Companies
  • 50.
    Genomics Report –November 201650 Interesting Late Stage Companies
  • 51.
    Genomics Report –November 201651 Interesting Late Stage Companies
  • 52.
    Genomics Report –November 201652 Top Funded Deadpooled Companies
  • 53.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 53
  • 54.
    Genomics Report –November 201654
  • 55.
    Genomics Report –November 201655 Genomics – Company List Clinical Genomics Bioinformatics Sequencing Technology Genetic Testing Liquid Biopsy Research Genomics 428 FUNDED COMPANIES AND 214 UNFUNDED COMPANIES COVERS THE FOLLOWING SECTORS
  • 56.
    Genomics Report –November 201656 Clinical Genomics (1/26) Company Overview Business Model Total Funding MDxHealth (2003, Irvine) Epigenetic tests for personalized cancer assessment and treatment. Seventure Partners, Idinvest Partners, IWT, EuroTransBio, IPSA Epigenetics $94.14M Epigenomics (1998, Berlin) Molecular Diagnostics for Cancer Wellcome Trust, 3i Group, MPM Capital, Abingworth, DVCG, BioChain, Creathor Venture, European Commission Epigenetics $52.05M OncoMethylome (2003, Antwerp) Diagnostics for early detection of cancer Epigenetics $16M Nucleix (2008, Rehovot) Develops non-invasive molecular cancer diagnostic tests Orbimed, Aurum Ventures Epigenetics $11.5M Oxford Biodynamics (2007, Oxford) Biomarker discovery based on epigenetics for personalized diagnostics. Epigenetics $11M MetaStat (2007, Montclair) Develops and commercializes diagnostic tests for the prediction of cancer metastasis. H.C. Wainwright Epigenetics $1.5M Oncgnostics (2012, Jena) Develops epigenetic biomarkers diagnostic tests High-Tech Grunderfonds, Bm-t Beteiligungsmanagement Thuringen, Sparkasse Jena Saale Holzland, STIFT Epigenetics Episona (2013, Los Angeles) Test kit using epigenetics to test male infertility. Epigenetics Go to BM List >> Bioinformatics
  • 57.
    Genomics Report –November 201657 Clinical Genomics (2/26) Company Overview Business Model Total Funding RiboMed Biotechnologies (1999, Carlsbad) Personalized diagnostics, prognostics and theranostics based on epigenetics. Epigenetics PrognosDx Health (2008, Palo Alto) Epigenetic testing technology to identify cancer Epigenetics Behavioral Diagnostics (2009, Iowa City) Epigenetics based substance use diagnostics National Institutes of Health Epigenetics Adaptive Biotechnologies (2009, Seattle) Engages in immune-based discoveries and diagnostics by combining high-throughput sequencing & bioinformatics to profile immune cell receptors genes. Illumina, Tiger Global Management, Matrix Partners, Casdin Capital, Celgene, Alexandria Real Estate Equities, BD Biosciences, Foresite Capital, Laboratory Corporation of America, Rock Springs Capital, Viking Global Investors, Senator Investment, National Heart Lung and Blood Institute Immunosequencing $404.35M Sequenta (2008, San Francisco) Immunesequencing for blood cancers Index Ventures, Mohr Davidow Ventures, Celgene, Foresite Capital Immunosequencing $43.46M Repertoire (2014, Ibaraki) TCR/BCR repertoire analysis services The University of Tokyo Edge Capital, Beyond Next Ventures Immunosequencing $6.47M MIODx (2014, San Jose) Diagnostics based on genomics and immunesequencing. Immunosequencing $1.5M Go to BM List >> Bioinformatics
  • 58.
    Genomics Report –November 201658 Clinical Genomics (3/26) Company Overview Business Model Total Funding ImmunID (2005, Grenoble) Molecular diagnostics using immune profiling Immunosequencing Enterome (2012, Paris) Therapeutic solutions for diseases associated with abnormalities of the gut microbiome (such as Inflammatory Bowel Diseases). Omnes Capital, Seventure Partners, Lundbeckfond Ventures, INRA Transfert, Lundbeckfonden, Nestle Health Science Microbiomics $39.16M uBiome (2012, San Francisco) Citizen science startup to sequence the human microbiome. Andreessen Horowitz, 500 Startups, Kapor Capital, Bansea, Linden Mobile Ventures, Three Bridges Venture Partners, Milliways Ventures, BoxGroup Microbiomics $4.97M GoodGut (2014, Girona) Diagnosis and treatment of digestive diseases based on intestinal microbiota analysis Caixa Capital Risc, BAGi Microbiomics $852.5k IS-Diagnostics (2011, Amsterdam) Provider of technology that enables the diagnosis, ongoing tracking and management of bacterial populations in various habitats. Microbiomics OmniBiome (2012, San Diego) Diagnostics, therapeutics for pregnancy-associated conditions where there is a substantive link with microbiome / microbiota dysbiosis. Microbiomics Quantibio (2014, Beijing) Focuses on the gene mapping of human gut microbiome Globals Tech. Microbiomics Go to BM List >> Bioinformatics
  • 59.
    Genomics Report –November 201659 Clinical Genomics (4/26) Go to BM List >> Bioinformatics
  • 60.
    Genomics Report –November 201660 Clinical Genomics (5/26) Go to BM List >> Bioinformatics
  • 61.
    Genomics Report –November 201661 Clinical Genomics (6/26) Go to BM List >> Bioinformatics
  • 62.
    Genomics Report –November 201662 Clinical Genomics (7/26) Go to BM List >> Bioinformatics
  • 63.
    Genomics Report –November 201663 Clinical Genomics (8/26) Go to BM List >> Bioinformatics
  • 64.
    Genomics Report –November 201664 Clinical Genomics (9/26) Go to BM List >> Bioinformatics
  • 65.
    Genomics Report –November 201665 Clinical Genomics (10/26) Go to BM List >> Bioinformatics
  • 66.
    Genomics Report –November 201666 Clinical Genomics (11/26) Go to BM List >> Bioinformatics
  • 67.
    Genomics Report –November 201667 Clinical Genomics (12/26) Go to BM List >> Bioinformatics
  • 68.
    Genomics Report –November 201668 Clinical Genomics (13/26) Go to BM List >> Bioinformatics
  • 69.
    Genomics Report –November 201669 Clinical Genomics (14/26) Go to BM List >> Bioinformatics
  • 70.
    Genomics Report –November 201670 Clinical Genomics (15/26) Go to BM List >> Bioinformatics
  • 71.
    Genomics Report –November 201671 Clinical Genomics (16/26) Go to BM List >> Bioinformatics
  • 72.
    Genomics Report –November 201672 Clinical Genomics (17/26) Go to BM List >> Bioinformatics
  • 73.
    Genomics Report –November 201673 Clinical Genomics (18/26) Go to BM List >> Bioinformatics
  • 74.
    Genomics Report –November 201674 Clinical Genomics (19/26) Go to BM List >> Bioinformatics
  • 75.
    Genomics Report –November 201675 Clinical Genomics (20/26) Go to BM List >> Bioinformatics
  • 76.
    Genomics Report –November 201676 Clinical Genomics (21/26) Go to BM List >> Bioinformatics
  • 77.
    Genomics Report –November 201677 Clinical Genomics (22/26) Go to BM List >> Bioinformatics
  • 78.
    Genomics Report –November 201678 Clinical Genomics (23/26) Go to BM List >> Bioinformatics
  • 79.
    Genomics Report –November 201679 Clinical Genomics (24/26) Go to BM List >> Bioinformatics
  • 80.
    Genomics Report –November 201680 Clinical Genomics (25/26) Go to BM List >> Bioinformatics
  • 81.
    Genomics Report –November 201681 Clinical Genomics (26/26) Go to BM List >> Bioinformatics
  • 82.
    Genomics Report –November 201682 Bioinformatics (1/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 83.
    Genomics Report –November 201683 Bioinformatics (2/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 84.
    Genomics Report –November 201684 Bioinformatics (3/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 85.
    Genomics Report –November 201685 Bioinformatics (4/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 86.
    Genomics Report –November 201686 Bioinformatics (5/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 87.
    Genomics Report –November 201687 Bioinformatics (6/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 88.
    Genomics Report –November 201688 Bioinformatics (7/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 89.
    Genomics Report –November 201689 Bioinformatics (8/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 90.
    Genomics Report –November 201690 Bioinformatics (9/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 91.
    Genomics Report –November 201691 Bioinformatics (10/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 92.
    Genomics Report –November 201692 Bioinformatics (11/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 93.
    Genomics Report –November 201693 Bioinformatics (12/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 94.
    Genomics Report –November 201694 Bioinformatics (13/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 95.
    Genomics Report –November 201695 Bioinformatics (14/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 96.
    Genomics Report –November 201696 Bioinformatics (15/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 97.
    Genomics Report –November 201697 Bioinformatics (16/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 98.
    Genomics Report –November 201698 Bioinformatics (17/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 99.
    Genomics Report –November 201699 Bioinformatics (18/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 100.
    Genomics Report –November 2016100 Bioinformatics (19/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 101.
    Genomics Report –November 2016101 Bioinformatics (20/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 102.
    Genomics Report –November 2016102 Bioinformatics (21/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 103.
    Genomics Report –November 2016103 Bioinformatics (22/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 104.
    Genomics Report –November 2016104 Bioinformatics (23/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 105.
    Genomics Report –November 2016105 Bioinformatics (24/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 106.
    Genomics Report –November 2016106 Bioinformatics (25/25) Clinical Genomics << Go to BM List >> Sequencing Technology
  • 107.
    Genomics Report –November 2016107 Sequencing Technology (1/5) Bioinformatics << Go to BM List >> Genetic Testing
  • 108.
    Genomics Report –November 2016108 Sequencing Technology (2/5) Bioinformatics << Go to BM List >> Genetic Testing
  • 109.
    Genomics Report –November 2016109 Sequencing Technology (3/5) Bioinformatics << Go to BM List >> Genetic Testing
  • 110.
    Genomics Report –November 2016110 Sequencing Technology (4/5) Bioinformatics << Go to BM List >> Genetic Testing
  • 111.
    Genomics Report –November 2016111 Sequencing Technology (5/5) Bioinformatics << Go to BM List >> Genetic Testing
  • 112.
    Genomics Report –November 2016112 Genetic Testing (1/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 113.
    Genomics Report –November 2016113 Genetic Testing (2/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 114.
    Genomics Report –November 2016114 Genetic Testing (3/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 115.
    Genomics Report –November 2016115 Genetic Testing (4/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 116.
    Genomics Report –November 2016116 Genetic Testing (5/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 117.
    Genomics Report –November 2016117 Genetic Testing (6/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 118.
    Genomics Report –November 2016118 Genetic Testing (7/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 119.
    Genomics Report –November 2016119 Genetic Testing (8/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 120.
    Genomics Report –November 2016120 Genetic Testing (9/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 121.
    Genomics Report –November 2016121 Genetic Testing (10/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 122.
    Genomics Report –November 2016122 Genetic Testing (11/11) Sequencing Technology << Go to BM List >> Liquid Biopsy
  • 123.
    Genomics Report –November 2016123 Liquid Biopsy (1/7) Genetic Testing << Go to BM List >> Research Genomics
  • 124.
    Genomics Report –November 2016124 Liquid Biopsy (2/7) Genetic Testing << Go to BM List >> Research Genomics
  • 125.
    Genomics Report –November 2016125 Liquid Biopsy (3/7) Genetic Testing << Go to BM List >> Research Genomics
  • 126.
    Genomics Report –November 2016126 Liquid Biopsy (4/7) Genetic Testing << Go to BM List >> Research Genomics
  • 127.
    Genomics Report –November 2016127 Liquid Biopsy (5/7) Genetic Testing << Go to BM List >> Research Genomics
  • 128.
    Genomics Report –November 2016128 Liquid Biopsy (6/7) Genetic Testing << Go to BM List >> Research Genomics
  • 129.
    Genomics Report –November 2016129 Liquid Biopsy (7/7) Genetic Testing << Go to BM List >> Research Genomics
  • 130.
    Genomics Report –November 2016130 Research Genomics (1/12) Liquid Biopsy << Go to BM List
  • 131.
    Genomics Report –November 2016131 Research Genomics (2/12) Liquid Biopsy << Go to BM List
  • 132.
    Genomics Report –November 2016132 Research Genomics (3/12) Liquid Biopsy << Go to BM List
  • 133.
    Genomics Report –November 2016133 Research Genomics (4/12) Liquid Biopsy << Go to BM List
  • 134.
    Genomics Report –November 2016134 Research Genomics (5/12) Liquid Biopsy << Go to BM List
  • 135.
    Genomics Report –November 2016135 Research Genomics (6/12) Liquid Biopsy << Go to BM List
  • 136.
    Genomics Report –November 2016136 Research Genomics (7/12) Liquid Biopsy << Go to BM List
  • 137.
    Genomics Report –November 2016137 Research Genomics (8/12) Liquid Biopsy << Go to BM List
  • 138.
    Genomics Report –November 2016138 Research Genomics (9/12) Liquid Biopsy << Go to BM List
  • 139.
    Genomics Report –November 2016139 Research Genomics (10/12) Liquid Biopsy << Go to BM List
  • 140.
    Genomics Report –November 2016140 Research Genomics (11/12) Liquid Biopsy << Go to BM List
  • 141.
    Genomics Report –November 2016141 Research Genomics (12/12) Liquid Biopsy << Go to BM List
  • 142.
    Genomics Report –November 2016 Scope of Report Entrepreneur Activity Investment Trend Who is Investing Exit Outlook - IPO, Acquisitions Sub Sector Analysis Interesting Companies Company List Team 142
  • 143.
    Genomics Report –November 2016143 Team 143 Shubham Garg Senior Analyst, Life Sciences Subhabrata Pal Lead Analyst, Life Sciences Vikash Peesapati Lead Analyst, Life Sciences
  • 144.
    Genomics Report –November 2016144